<DOC>
	<DOC>NCT01614028</DOC>
	<brief_summary>This study aims to investigate short-term outcomes following the use of two femoral stems used during Total Hip arthoplasty: the Fitmore Femoral stem and the M/L Taper Femoral stem.</brief_summary>
	<brief_title>Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem</brief_title>
	<detailed_description />
	<criteria>Patient signed an IRB, study specific informed patient consent. Patient is a male or nonpregnant female age 18 years or older at the time of study device implantation. Patient has primary diagnosis of noninflammatory degenerative joint disease. Patient is a candidate for primary cementless total hip replacement. Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation. Patient has a Body Mass Index (BMI) &gt; 40 Kg/m2. Patient has an active or suspected infection at the time of device implantation. Patient is immunologically suppressed. Patient requires revision surgery of a previously implanted total hip replacement. Patient has a known sensitivity to device materials.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>